Similar articles for PMID: 29383638

Year	Number of Results
2003	1
2006	2
2007	3
2008	1
2009	6
2010	1
2011	6
2012	8
2013	9
2014	12
2015	8
2016	15
2017	21
2018	17
2019	13
2020	18
2021	11
2022	7
2023	2
2024	0

1

Possible mechanisms of direct cardiovascular impact of GLP-1 agonists and DPP4 inhibitors.

Bistola V, Lambadiari V, Dimitriadis G, Ioannidis I, Makrilakis K, Tentolouris N, Tsapas A, Parissis J. Bistola V, et al. Heart Fail Rev. 2018 May;23(3):377-388. doi: 10.1007/s10741-018-9674-3. Heart Fail Rev. 2018. PMID: 29383638 Review.

2

Cardiovascular effects of incretins in diabetes.

Advani A, Bugyei-Twum A, Connelly KA. Advani A, et al. Can J Diabetes. 2013 Oct;37(5):309-14. doi: 10.1016/j.jcjd.2013.06.010. Can J Diabetes. 2013. PMID: 24500557 Review.

3

Network meta-analysis of cardiovascular outcomes in randomized controlled trials of new antidiabetic drugs.

Fei Y, Tsoi MF, Kumana CR, Cheung TT, Cheung BMY. Fei Y, et al. Int J Cardiol. 2018 Mar 1;254:291-296. doi: 10.1016/j.ijcard.2017.12.039. Epub 2017 Dec 20. Int J Cardiol. 2018. PMID: 29277321

4

Cardiovascular safety of therapies for type 2 diabetes.

Gupta P, White WB. Gupta P, et al. Expert Opin Drug Saf. 2017 Jan;16(1):13-25. doi: 10.1080/14740338.2017.1239707. Epub 2016 Oct 11. Expert Opin Drug Saf. 2017. PMID: 27652617 Free PMC article. Review.

5

Cardiovascular protection by DPP-4 inhibitors in preclinical studies: an updated review of molecular mechanisms.

Zakaria EM, Tawfeek WM, Hassanin MH, Hassaballah MY. Zakaria EM, et al. Naunyn Schmiedebergs Arch Pharmacol. 2022 Nov;395(11):1357-1372. doi: 10.1007/s00210-022-02279-3. Epub 2022 Aug 10. Naunyn Schmiedebergs Arch Pharmacol. 2022. PMID: 35945358 Free PMC article. Review.

6

[Research progress of mechanisms through which dipeptidyl peptidase-4 inhibitors regulate glycemia].

Wang JS. Wang JS. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2013 Apr;35(2):229-33. doi: 10.3881/j.issn.1000-503X.2013.02.019. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2013. PMID: 23643015 Review. Chinese.

7

Current antihyperglycemic treatment strategies for patients with type 2 diabetes mellitus.

Blonde L. Blonde L. Cleve Clin J Med. 2009 Dec;76 Suppl 5:S4-11. doi: 10.3949/ccjm.76.s5.02. Cleve Clin J Med. 2009. PMID: 19952303 Free article. Review.

8

A Review on the Effects of New Anti-Diabetic Drugs on Platelet Function.

Yaribeygi H, Atkin SL, Jamialahmadi T, Sahebkar A. Yaribeygi H, et al. Endocr Metab Immune Disord Drug Targets. 2020;20(3):328-334. doi: 10.2174/1871530319666191014110414. Endocr Metab Immune Disord Drug Targets. 2020. PMID: 31612835 Review.

9

Cardiovascular effects of antidiabetic drugs.

Sørensen AM, Christensen MB. Sørensen AM, et al. Drugs Today (Barc). 2018 Sep;54(9):547-559. doi: 10.1358/dot.2018.54.9.2872500. Drugs Today (Barc). 2018. PMID: 30303495 Review.

10

Anti-Hyperglycemic Agents for the Treatment of Type 2 Diabetes Mellitus: Role in Cardioprotection During the Last Decade.

Kocyigit D, Gurses KM, Yalcin MU, Tokgozoglu L. Kocyigit D, et al. Endocr Metab Immune Disord Drug Targets. 2017;17(1):19-31. doi: 10.2174/1871530317666170424101846. Endocr Metab Immune Disord Drug Targets. 2017. PMID: 28440199 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

142 results

Results by year